Clindamycin Phosphate

Product Description

Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the warning box, before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (eg, erythromycin).

Highly Pure Pharmaceutical Antibiotic

Clindamycin Phosphate, with a remarkable purity of 99%, is suited for critical medical applications. Its fine, crystalline form makes it ideal as an active pharmaceutical ingredient or intermediate in antibiotic preparations. This trusted pharmaceutical grade powder is well-suited for regulated manufacturing conditions and delivers reliable consistency batch after batch.


Extensive Shelf Life and Stability

With a shelf life of 5 years, Clindamycin Phosphate offers excellent inventory management and long-term storage benefits for suppliers and manufacturers. Its stable crystalline structure ensures the compound maintains efficacy throughout its storage and handling lifecycle, reducing concerns over quality loss.